Assure Holdings Corp. (Assure), a provider of intraoperative neuromonitoring and remote neurology services, has announced an extension to the expiration date of its Convertible Note Exchange Offer. The offer pertains to the company's 9% Convertible Debentures due in 2023 and 2024. Initially set to expire on July 19, 2024, the offer has been extended multiple times, with the latest extension pushing the deadline to 11:59 p.m. (Denver Time) on September 6, 2024. As of August 23, 2024, $2.0 million in principal face amount of the debentures had been tendered. The exchange offer allows debenture holders to exchange each $1,000 claim for 238.44 shares of Assure's common stock. The terms of the offer remain unchanged except for the new expiration date. Assure has advised debenture holders to read the offer documents carefully before deciding to participate in the exchange offer.

Assure Holdings Corp. (Assure), a provider of intraoperative neuromonitoring and remote neurology services, has announced an extension to the expiration date of its Convertible Note Exchange Offer. The offer pertains to the company's 9% Convertible Debentures due in 2023 and 2024. Initially set to expire on July 19, 2024, the offer has been extended multiple times, with the latest extension pushing the deadline to 11:59 p.m. (Denver Time) on September 6, 2024. As of August 23, 2024, $2.0 million in principal face amount of the debentures had been tendered. The exchange offer allows debenture holders to exchange each $1,000 claim for 238.44 shares of Assure's common stock. The terms of the offer remain unchanged except for the new expiration date. Assure has advised debenture holders to read the offer documents carefully before deciding to participate in the exchange offer.